Posters

      Design for a Population Study of Exposure of U.S. Adult Smokers to Cigarette Smoke

      R-Walk, R-A. Walk.; Carter, W. H.; Carchman, R. A.; Gear, J. C.; Gomm, W.; Gennings, C.; Kinser, R. D.; Leyden, D. E.; Tricker, A. R.; von Holt, K.

      Conference date
      Jul 8, 2001
      Conference name
      International Congress of Toxicology (ICT) 2001
      Link to more information
      Link to more information
      Topic
      Summary

      Determination of the exposure of adult smokers to cigarette smoke is of significance to the public health community, and integral to the development of reduced harm cigarette products. To evaluate future reduced harm products, a baseline study has been designed to determine actual exposure of U.S. adult smokers to cigarettes currently available in the U.S. market. The study population will include adult smokers of all major U.S. brands and include all 'tar'/nicotine yield categories. Smoke constituents and relevant biomarkers of exposure and effect to be determined in this study have been identified. A pilot study has been incorporated in the experimental design and results from the pilot will be used to estimate sample size for the baseline study. A questionnaire has been constructed to characterize smoking behavior and identify sources of confounding for biomarkers, both dietary and environmental. A statistical plan for data assessment and evaluation has also been devised. Details of this experimental design will be presented. 

      Related Publications

      Nicotine Pharmacokinetics of THS Single Use of a Regular or a Menthol Stick Compared to CIG

      Clinical

      Reduction in exposure to selected harmful and potentially harmful constituents approaching those observed upon smoking abstinence in smokers switching to the menthol Tobacco Heating System 2.2 for three months (Part 1)

      Clinical

      Reduction in exposure to selected harmful and potentially harmful constituents approaching those observed upon smoking abstinence in smokers switching to the menthol Tobacco Heating System 2.2 for three months (Part 1)

      Clinical

      Meta-analysis of the effects of smoking and smoking cessation on triglyceride levels

      Clinical

      Smoking and apolipoprotein levels: A meta-analysis of published data

      Clinical

      Effect of switching from cigarette smoking to the use of the tobacco heating system on periodontitis treatment outcome: Periodontal parameter results from a multicenter Japanese study

      Clinical

      PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts to develop and assess products that have the potential to reduce individual risk and population harm associated with tobacco use. This site is for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not for advertising or marketing. It is not intended for use by consumers.

      Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. Our RRPs are smoke-free products that produce an aerosol that contains far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.